跳至主要内容
临床试验/NL-OMON38332
NL-OMON38332已完成不适用

A single centre, prospective, randomised, double-blind, placebo controlled, sequential, dose-escalating phase I study to assess the safety and tolerability of intravenously infused single doses of OPN-305 in healthy subjects. - OPN-305 SAD study

Opsona Therapeutics Ltd.0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy male volunteers; 18 - 60 years; BMI 18.0 - 28.9 kg/m2; moderate or non-smoker.

排除标准

  • Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 90 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.

研究者

相似试验

进行中(未招募)
不适用
A prospective, single centre, randomised, double-blind, placebo controlled trial to assess the analgesic effects of one week treatment with anti-TNF in patients with lower back and leg pain. - Pilot study of anti-TNF use in lower back and leg pain patientswower back and leg pain
EUCTR2005-003722-26-GBBarts and the London NHS Trust40
进行中(未招募)
1 期
A single center randomised placebo controlled study to test a novel topical formulation containing Niclosamide, an antibiotic.AntibioTx has developed a topical product (ATx201) for treatment of infected eczema and infected atopic dermatitis. These infections are predominantly caused by Staphyllococcus aureus and various species of Streptococcus. Treatment of these infections is plagued by inactivity of or resistance towards the main topical antibiotics (fucidic acid, mupirocin and retapamulin).MedDRA version: 20.0Level: HLTClassification code 10040788Term: Skin and subcutaneous tissue bacterial infectionsSystem Organ Class: 100000004858
EUCTR2016-003501-33-ATAntibioTx ApS76
进行中(未招募)
1 期
A single-center, prospective, randomized, double-blind, intra-patient (left-to-right) placebo-controlled, pilot study to assess the efficacy and safety of a betamethasone valerate 0.1% medicated plaster in the treatment of finger nail psoriasisail Psoriasis
EUCTR2014-000291-25-ITIBSA Institut Biochimique S.A.30
进行中(未招募)
1 期
A clinical study investigating the analgesic effects of Midazolam compared to an inactive substance (placebo) in human volunteer subjects with the use of Fentanyl as an active (i.e. analgesic) control substance whereby all participants receive all treatments.nociceptive pain
EUCTR2015-004097-15-ATWilhelminenspital
已完成
不适用
A prospective, single-centre, randomised, double-blind, placebo-controlled trial to assess the analgesic effects of one-week treatment with anti-tumour necrotising factor (TNF) in patients with lower back and leg pai
ISRCTN14943354Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)40
A single centre, prospective, randomised,... | 临床试验